Back to Search
DR. JOSEPH W. BASLER M.D.
M.D.
Urology Physician
NPI: 1801802566IndividualAccepts Medicare
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
K8711(TX)
Education
UNIVERSITY OF MISSOURI, COLUMBIA SCHOOL OF MEDICINE
Class of 1984
Research & Publications (20)
Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective inhibitors for prostate cancer chemoprevention.
PMID 14713756·J Urol·2004
6-review
Veterans Affairs Cooperative Studies Program study 553: Chemotherapy after prostatectomy, a phase III randomized study of prostatectomy versus prostatectomy with adjuvant docetaxel for patients with high-risk, localized prostate cancer.
PMID 18407333·Urology·2008
6-review
Construction and optimization of a CC49-based scFv-beta-lactamase fusion protein for ADEPT.
PMID 16436454·Protein Eng Des Sel·2006
8-other
Current status of lymph node-positive prostate cancer: Incidence and predictors of outcome.
PMID 16795064·Cancer·2006
6-review
Evaluation of mechanical bowel preparation methods in urinary diversion surgery.
PMID 17076946·Can J Urol·2006
4-observational
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study.
PMID 16609032·Clin Cancer Res·2006
4-observational
Metastatic prostate cancer-does treatment of the primary tumor matter?
PMID 16952615·J Urol·2006
6-review
Prevalence of osteopenia and osteoporosis by central and peripheral bone mineral density in men with prostate cancer during androgen-deprivation therapy.
PMID 16413352·Urology·2006
8-other
The modulation of prostate cancer risk with alpha-tocopherol: a pilot randomized, controlled clinical trial.
PMID 16006884·J Urol·2005
3-trial
The association of body mass index and prostate-specific antigen in a population-based study.
PMID 15668913·Cancer·2005
8-other
Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated?
PMID 15869722·Curr Urol Rep·2005
6-review
Screening for prostate cancer: opportunities and challenges.
PMID 16226689·Surg Oncol Clin N Am·2005
6-review
What's new in the field of prostate cancer chemoprevention?
PMID 15066236·Curr Oncol Rep·2004
6-review
The potential role of cyclooxygenase-2 inhibitors and 5alpha-reductase inhibitors in the prevention of urologic conditions.
PMID 15123401·Urol Clin North Am·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8300 FLOYD CURL DR FL 4
SAN ANTONIO, TX 78229 - Phone
- (210) 450-9600
Quick Facts
- NPI
- 1801802566
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 42
- Publications
- 20
Are you this provider?
Claim Your Profile